Literature DB >> 10329852

IL-9 pathway in asthma: new therapeutic targets for allergic inflammatory disorders.

R C Levitt1, M P McLane, D MacDonald, V Ferrante, C Weiss, T Zhou, K J Holroyd, N C Nicolaides.   

Abstract

BACKGROUND: Asthma is a complex heritable inflammatory disorder of the airways associated with clinical signs of allergic inflammation and bronchial hyperresponsiveness (BHR). The incidence of asthma continues to rise in industrialized countries despite advances in the identification of cellular and molecular mediators that are associated with the disease. Because of its importance in human health, additional research and alternative therapeutic strategies are justified to create more effective treatments for this debilitating disease.
OBJECTIVE: Studies use recombinant inbred mice to demonstrate that BHR in mouse models of asthma is associated with a genetic alteration at the IL-9 locus, where IL-9 expression in lung is strongly associated with bronchial responsiveness. We have investigated the ability of intratracheal instilled IL-9 to induce asthmatic-like responses in naive C57BL/6 (B6) mice, which express very low levels of IL-9.
METHODS: IL-9 or vehicle was intratracheal instilled in naive B6 mice for 10 days. Mice were analyzed for effects on BHR, lung eosinophilia, and serum total IgE levels.
RESULTS: Phenotypic effects of B6 mice instilled with IL-9 were increased eosinophils in the bronchoalveolar lavage and significantly elevated serum total IgE. Moreover, IL-9 was found to induce IL-5Ralpha in vivo and in vitro, suggesting a potential mechanism for the novel actions described for IL-9 on eosinophils.
CONCLUSION: Increased levels of IL-9 in the airway of naive B6 mice induced lung eosinophilia and serum total IgE levels, which are 2 clinical features of asthma. These data support a central role for the IL-9 pathway in the complex pathogenesis of allergic inflammation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329852     DOI: 10.1016/s0091-6749(99)70165-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  16 in total

Review 1.  Resolution of allergic asthma.

Authors:  Susetta Finotto
Journal:  Semin Immunopathol       Date:  2019-11-08       Impact factor: 9.623

2.  Amazing IL-9: revealing a new function for an "old" cytokine.

Authors:  Edgar Schmitt; Tobias Bopp
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

Review 3.  Immunobiology of critical pediatric asthma.

Authors:  Stacey Galowitz; Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2015-02       Impact factor: 8.667

4.  From bench to bedside: Therapeutic potential of interleukin-9 in the treatment of asthma.

Authors:  Fang Gong; Yu-Hong Pan; Xuan Huang; Hua-Yan Zhu; Dong-Lin Jiang
Journal:  Exp Ther Med       Date:  2017-01-04       Impact factor: 2.447

5.  The tick salivary protein sialostatin L inhibits the Th9-derived production of the asthma-promoting cytokine IL-9 and is effective in the prevention of experimental asthma.

Authors:  Helena Horka; Valérie Staudt; Matthias Klein; Christian Taube; Sebastian Reuter; Nina Dehzad; John F Andersen; Jan Kopecky; Hansjörg Schild; Michalis Kotsyfakis; Markus Hoffmann; Bastian Gerlitzki; Michael Stassen; Tobias Bopp; Edgar Schmitt
Journal:  J Immunol       Date:  2012-02-10       Impact factor: 5.422

6.  Cell-mediated immune responses to respiratory syncytial virus infection: magnitude, kinetics, and correlates with morbidity and age.

Authors:  Bessey Geevarghese; Adriana Weinberg
Journal:  Hum Vaccin Immunother       Date:  2014-02-10       Impact factor: 3.452

Review 7.  IL-9-producing T cells: potential players in allergy and cancer.

Authors:  Pornpimon Angkasekwinai; Chen Dong
Journal:  Nat Rev Immunol       Date:  2020-08-12       Impact factor: 53.106

8.  The other T helper cells in asthma pathogenesis.

Authors:  Christina Vock; Hans-Peter Hauber; Michael Wegmann
Journal:  J Allergy (Cairo)       Date:  2010-07-25

9.  Global analysis of the eukaryotic pathways and networks regulated by Salmonella typhimurium in mouse intestinal infection in vivo.

Authors:  Xingyin Liu; Rong Lu; Yinglin Xia; Jun Sun
Journal:  BMC Genomics       Date:  2010-12-20       Impact factor: 3.969

10.  IL-9 induces VEGF secretion from human mast cells and IL-9/IL-9 receptor genes are overexpressed in atopic dermatitis.

Authors:  Nikolaos Sismanopoulos; Danae A Delivanis; Konstantinos D Alysandratos; Asimenia Angelidou; Magdalini Vasiadi; Anastasia Therianou; Theoharis C Theoharides
Journal:  PLoS One       Date:  2012-03-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.